p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest

Xiao Qi Wang1, Eric J Stanbridge, Xiaoyan Lao

  • 1Department of Microbiology and Molecular Genetics, University of California Irvine, School of Medicine, Irvine, California 92697, USA.

Radiation Research
|December 20, 2007
PubMed

Insights

Checkpoint kinase inhibitors can sensitize cancer cells to chemotherapy. This study reveals that the protein p53 plays a key role in maintaining the G2 checkpoint, preventing its abrogation by certain inhibitors in p53+/+ cells.

Area of Science:

  • Cell cycle regulation
  • Cancer therapy
  • DNA damage response

Background:

  • Checkpoint kinases are targets for cancer therapy, potentially enhancing chemosensitivity.
  • Checkpoint kinase inhibitors often disrupt the DNA damage-induced G2 checkpoint more in p53-deficient (p53-/-) than in p53-proficient (p53+/+) cells.
  • The precise mechanisms by which p53 prevents G2 checkpoint abrogation remain unclear.

Purpose of the Study:

  • To investigate the role of p53 in preventing the abrogation of the gamma-radiation-induced G2 checkpoint by different checkpoint inhibitors.
  • To compare the effects of caffeine, staurosporine, and UCN-01 on G2 arrest in p53+/+ and p53-/- human diploid fibroblasts.

Main Methods:

  • Utilized normal human diploid p53+/+ and p53-/- fibroblasts as model systems.
  • Compared the effects of three checkpoint inhibitors (caffeine, staurosporine, UCN-01) on gamma-radiation-induced G2 arrest.
  • Assessed Chk1 and Chk2 phosphorylation status in the presence of inhibitors and varying p53 expression.

Main Results:

  • Caffeine abrogated G2 arrest in p53+/+ cells, while staurosporine and UCN-01 did not. All three inhibitors abrogated G2 arrest in p53-/- cells.
  • Chk2 phosphorylation was maintained in both cell types with all inhibitors.
  • Chk1 phosphorylation was maintained with staurosporine and UCN-01 in p53+/+ cells, but inhibited by caffeine regardless of p53 status.
  • The pathway involving Chk1 phosphorylation, Cdc25A degradation, and cyclin B1/Cdk1 inhibition was resistant to staurosporine and UCN-01 in p53+/+ cells.
  • Sustained Chk1 phosphorylation in p53+/+ cells treated with staurosporine/UCN-01 correlated with p53 phosphorylation.

Conclusions:

  • The study highlights a unique role for Chk1 in maintaining the G2 checkpoint in p53+/+ cells.
  • p53 appears to protect the G2 checkpoint from abrogation by specific checkpoint inhibitors.
  • These findings contribute to understanding the differential effects of checkpoint inhibitors based on p53 status in cancer therapy.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...